Dr. Brittany Weaver is a pharmacist who is specialized in Oncology in Franklin, Indiana. Patients can reach her at 1159 W Jefferson St, Franklin or contact her on 317-736-3300. Active license number of Dr. Brittany Weaver is 26023248A for Oncology in Indiana. Dr. Brittany Weaver is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Brittany Weaver speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Brittany Weaver
Specialization:
Oncology
Credentials:
PHARM D
Gender:
Female
Location:
1159 W Jefferson St, Franklin, Indiana, 46131-2794
Phone:
317-736-3300
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Brittany Weaver are as mentioned below.
NPI Number:
1740903368
NPI Enumeration Date:
20 Sep, 2022
NPI Last Update On:
24 May, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Brittany Weaver are as mentioned below.
Specialization
License Number
State
Status
Oncology
26023248A
Indiana
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1159 W Jefferson St, Franklin, Indiana
Zip:
46131-2794
Phone Number:
317-736-3300
Fax Number:
--
Patients can reach Dr. Brittany Weaver at 1159 W Jefferson St, Franklin, Indiana or can call on phone at 317-736-3300.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.